GMDAQ — Gamida Cell Income Statement
0.000.00%
- $2.62m
- $35.61m
- $1.78m
Annual income statement for Gamida Cell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 1.78 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 0.33 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 48.2 | 60.9 | 87.2 | 75 | 74.8 |
Operating Profit | -48.2 | -60.9 | -87.2 | -75 | -73 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -34.4 | -61.6 | -89.8 | -79.4 | -63 |
Provision for Income Taxes | |||||
Net Income After Taxes | -34.4 | -61.6 | -89.8 | -79.4 | -63 |
Net Income Before Extraordinary Items | |||||
Net Income | -34.4 | -61.6 | -89.8 | -79.4 | -63 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -34.4 | -61.6 | -89.8 | -79.4 | -63 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.02 | -1.41 | -1.52 | -1.24 | -0.569 |